GENEVA, June 16 -- ADC THERAPEUTICS SA (BiopoleRoute de la Corniche 3B1066 Epalinges) filed a patent application (PCT/EP2024/084823) for "ANTI-PSMA ANTIBODY DRUG CONJUGATES COMPRISING EXATECAN" on Dec 05, 2024. With publication no. WO/2025/120040, the details related to the patent application was published on Jun 12, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): HOGG, Paul (c/o ADC Therapeutics (UK) Ltd., I-HUB, Imperial College White City Campus, 84 Wood LaneLondon Greater London W12 0BZ), VEILLARD, Nicolas (c/o ADC Therapeutics (UK) Ltd., I-HUB, Imperial College White City Campus, 84 Woo...